8 ms·

now comes the time for the pricing

• aantix 8y ago
  With those in the U.S. subsidizing the rest of the world.
  • Brakenshire 8y ago
    Seeing as more is spent on marketing than on drug development, and pharmaceutical marketing is heavily restricted in many other countries, I suspect the only subsidization which is happening is from US consumers to US marketing companies.
    • aantix 8y ago
      Are you arguing that only Americans would know about the drugs created by American companies..? I'm sure a European specialist could do a quick Google search to find the latest options in care, including any newly approved drugs globally. The cost of developing a new drug is insane. http://blogs.sciencemag.org/pipeline/archives/2017/10/18/drug-development-costs-revisited http://blogs.sciencemag.org/pipeline/archives/2017/10/18/dru... When everyone demands a discount, the guy paying full price ends up picking up the rest of the tab.
• epmaybe 8y ago
  It's already known what the expected pricing for CAR-T therapy will be, considering the first of these therapies was approved last year for pediatric leukemia (KYMRIAH/tisagenlecleucel). Expect around $475,000.
  • klipt 8y ago
    Considering that surgery can cost close to that and isn't a full cure, CAR-T is not that expensive relatively speaking.